Participants (N = 52) n (%)
Sex
Female 27 (51.9%)
Male 25 (48.1%)
Race/Ethnicity
Non-Hispanic white
25 (48.1%)
Non-Hispanic black
14 (26.9%)
Hispanic
10 (19.2%)
Asian
3 (5.8%)
Age at primary malignancy diagnosis, in years (mean / SD / range)
12.9 ± 7.1 (0 - 25)
0-11 years old
19 (36.5%)
12-17 years old
15 (28.9%)
≥18 years old
18 (34.6%)
Age at assessment, in years (mean / SD / range)
13.8 ± 7.2 (0 - 25)
0-11 years old
18 (34.6%)
12-17 years old
14 (26.9%)
≥18 years old
20 (38.5%)
Primary malignancy diagnosis
Leukemia
30 (57.7%)
CNS tumor
3 (5.8%)
Hodgkin lymphoma
6 (11.5%)
Non-Hodgkin lymphoma
2 (3.9%)
Neuroblastoma
4 (7.7%)
Wilms tumor
2 (3.9%)
Soft tissue sarcoma
1 (1.9%)
Bone tumor
2 (3.9%)
Other*
2 (3.9%)
Treatment type
Surgery 16 (30.8%)
Radiation 7 (13.5%)
Chemotherapy 51 (91.8%)
Stem cell transplantation 4 (7.7%)
Other 3 (5.8%)
Health insurance
Private
36 (69.2%)
Medicaid
14 (26.9%)
Other
2 (3.9%)
Annual household income
Less than $20,000
11 (21.2%)
$20,000 to $49,999
5 (9.6%)
$50,000 to $99,999
12 (23.1%)
$100,000 to $149,999
7 (13.5%)
$150,000 to $199,999
4 (7.7%)
$200,000 or more
5 (9.6%)
Don’t know/Unsure
8 (15.4%)
Any chronic health condition
27 (51.9%)
Vision/Eye problems 16 (30.8%)
Hearing problems 0 (0%)
Speech problems 3 (5.8%)
Any endocrine 1 (1.9%)
Any cardiac/vascular 3 (5.8%)
Any respiratory 3 (5.8%)
Any GI/digestive 1 (1.9%)
Any renal 2 (3.8%)
Any brain/nervous system 3 (5.8%)
Any musculoskeletal 0 (0%)
Chronic pain 1 (1.9%)
Any psychiatric/mental health diagnosis 18 (34.6%)
Substance misuse
Tobacco use** 8 (15.4%)
Risky alcohol use*** 12 (23%)
Recreational/Prescription drug use**** 10 (19.2%)